Log in to your Inderes Free account to see all free content on this page.
Vitrolife
93.30 SEK
+0.81 %
Less than 1K followers
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vitrolife
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 867.0 | 960.0 | 3,609.0 | 842.0 | 871.0 | 835.0 | 892.0 | 3,440.0 |
| EBITDA | 289.0 | 337.0 | 962.0 | 257.0 | 243.0 | 253.0 | 196.0 | 949.0 |
| EBIT | 174.0 | 224.0 | 783.0 | 151.0 | 137.0 | 144.0 | -5,267.0 | -4,835.0 |
| EBIT-% | 20.1 % | 23.3 % | 21.7 % | 17.9 % | 15.7 % | 17.2 % | -590.5 % | -140.6 % |
| Profit before taxes | 155.0 | 183.0 | 674.0 | 141.0 | 132.0 | 131.0 | -5,290.0 | -4,886.0 |
| Net income | 116.0 | 140.0 | 514.0 | 100.0 | 100.0 | 102.0 | -5,315.0 | -5,013.0 |
Login required
This content is only available for logged in users